๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
RATIONALE: Vaccines made from a patient's dendritic cells and tumor cells m...
Status
Completed
Location
Norris Cotton Cancer Center at Dartmouth - Hitchcock Medical Center
Start Date
2003-12
Trial ID
NCT00085436
Treatments Being Tested
Adoptive T cell therapy (ACT) with tumor infiltrating lymphocytes (TIL) has...
Status
Completed
Location
Center for Cancer Immune Therapy Dept. of Hematology/oncology
Start Date
2016-12
Trial ID
NCT02926053
RATIONALE: Biological therapies, such as cellular adoptive immunotherapy, s...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
1998-12
Trial ID
NCT00107354
RATIONALE: Aldesleukin may stimulate the white blood cells to kill tumor ce...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2008-06
Trial ID
NCT00726739
Treatments Being Tested
RATIONALE: Interleukin-2 may stimulate a person's white blood cells to kill...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
1998-03
Trial ID
NCT00009698
Treatments Being Tested
This study is a randomized, placebo-controlled, phase 2a trial to study the...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Neurological Clinical Research Institute
Start Date
2019-08-07
Trial ID
NCT04055623
Randomized phase III trial to compare the effectiveness of different chemot...
Status
Completed
Location
Children's Oncology Group
Start Date
1996-08
Trial ID
NCT00002798
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
National Institute on Aging - Baltimore
Start Date
1999-09
Trial ID
NCT00003993
Treatments Being Tested
Adoptive T cell therapy with tumor infiltrating lymphocytes (TIL) has achie...
Status
Completed
Location
Center for Cancer Immune Therapy Dept. of Hematology/oncology
Start Date
2015-07
Trial ID
NCT02482090
Treatments Being Tested
Multidrug-resistant tuberculosis (MDR-TB) has emerged as a challenge worldw...
Status
Unknown
Location
the First Affiliated Hospital of Nanjing Medical University
Start Date
2009-06-01
Trial ID
NCT03069534
Treatments Being Tested